Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02489 (CTD-2589M5.4) is a human long intergenic non-protein coding RNA gene, a subtype of long non-coding RNA (lncRNA) that does not overlap with protein-coding genes[1][3][5]. LincRNAs typically exceed 200 nucleotides, are autonomously transcribed, and are distinguished by their intergenic genomic localization[1][3]. They participate in regulating gene expression at both transcriptional and post-transcriptional levels, often by scaffolding protein complexes, modulating chromatin architecture, and influencing neighboring gene expression, usually with remarkable tissue specificity[1]. Many lincRNAs, including LINC02489, are still poorly characterized functionally; their roles are inferred based on properties common to the class, but specific data for LINC02489 are lacking. LincRNAs as a group are increasingly recognized for their roles in development, differentiation, and disease, but LINC02489 itself has not been linked as a therapeutic target, biomarker, or in tractable drug-disease biology as of the current literature[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2489 (LINC02489).